DE602007008349D1 - Kit zur Behandlung von Erkrankungen im Zusammenhang mit systemischen Entzündungen - Google Patents

Kit zur Behandlung von Erkrankungen im Zusammenhang mit systemischen Entzündungen

Info

Publication number
DE602007008349D1
DE602007008349D1 DE602007008349T DE602007008349T DE602007008349D1 DE 602007008349 D1 DE602007008349 D1 DE 602007008349D1 DE 602007008349 T DE602007008349 T DE 602007008349T DE 602007008349 T DE602007008349 T DE 602007008349T DE 602007008349 D1 DE602007008349 D1 DE 602007008349D1
Authority
DE
Germany
Prior art keywords
systemic
kit
pore size
mediators
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008349T
Other languages
English (en)
Inventor
Mauro Atti
Mary Lou Wratten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bellco SRL
Original Assignee
Bellco SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellco SRL filed Critical Bellco SRL
Publication of DE602007008349D1 publication Critical patent/DE602007008349D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • External Artificial Organs (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602007008349T 2007-01-12 2007-01-12 Kit zur Behandlung von Erkrankungen im Zusammenhang mit systemischen Entzündungen Active DE602007008349D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07425010A EP1944046B1 (de) 2007-01-12 2007-01-12 Kit zur Behandlung von Erkrankungen im Zusammenhang mit systemischen Entzündungen

Publications (1)

Publication Number Publication Date
DE602007008349D1 true DE602007008349D1 (de) 2010-09-23

Family

ID=38055553

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008349T Active DE602007008349D1 (de) 2007-01-12 2007-01-12 Kit zur Behandlung von Erkrankungen im Zusammenhang mit systemischen Entzündungen

Country Status (12)

Country Link
US (2) US20100044312A1 (de)
EP (1) EP1944046B1 (de)
KR (1) KR101456120B1 (de)
CN (1) CN101657224B (de)
AT (1) ATE477009T1 (de)
CA (1) CA2675324C (de)
CO (1) CO6231006A2 (de)
DE (1) DE602007008349D1 (de)
ES (1) ES2348189T3 (de)
MX (1) MX340241B (de)
RU (1) RU2452518C2 (de)
WO (1) WO2008084111A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8672869B2 (en) * 2007-10-30 2014-03-18 Bellco S.R.L. Kit, system and method of treating myeloma patients
CN102335465A (zh) * 2010-07-27 2012-02-01 天津市阳权医疗器械有限公司 治疗尿毒症血液灌流器
EP2679302A1 (de) 2012-06-28 2014-01-01 Zentrum für biomedizinische Technologie der Donau- Universität Krems Selektives Sorptionsmittel für die extrakorporale Blutreinigung
EP2735326B1 (de) * 2012-11-26 2017-03-08 Gambro Lundia AB Leberunterstützungssytem
CN104096278A (zh) * 2014-08-07 2014-10-15 天津市阳权医疗器械有限公司 一种专用于吸附“埃博拉”属线、丝状病毒的血液灌流器
WO2016030357A1 (de) 2014-08-26 2016-03-03 3M Innovative Properties Company System zur entfernung von proinflammatorischen mediatoren sowie von granulozyten und monozyten aus blut
TWI595897B (zh) * 2016-03-31 2017-08-21 禾研科技股份有限公司 血液淨化系統
US11562078B2 (en) 2021-04-16 2023-01-24 OneTrust, LLC Assessing and managing computational risk involved with integrating third party computing functionality within a computing system
KR20240000953A (ko) * 2022-06-24 2024-01-03 서울대학교산학협력단 창상 피복재 및 케모카인 흡착 입자를 포함하는 상처 치료용 약학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2041717C1 (ru) * 1992-07-21 1995-08-20 Александр Николаевич Николаенко Биологически активное средство, способ его получения и препарат, содержащий указанное средство, и способ использования препарата
DE4309410A1 (de) * 1993-03-19 1995-02-16 Stange Jan Material, Verfahren und Einrichtung zur selektiven Trennung frei gelöster und stoffgebundener Stoffe aus flüssigen Stoffgemischen sowie Verfahren zur Herstellung des Materials
DE69605395T2 (de) * 1996-02-06 2000-06-08 Bellco Spa Vorrichtung zum extrakoporealen Entfernen von Toxinen, insbesondere Zytokinen
US6287516B1 (en) * 1998-07-10 2001-09-11 Immunocept, L.L.C. Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease
WO2003009885A2 (en) * 2001-07-25 2003-02-06 Immunocept, L.L.C. Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
US20040182783A1 (en) * 2003-03-17 2004-09-23 Walker Kimberly A. Filter and concentrator device for treatment of blood
WO2006002151A1 (en) * 2004-06-21 2006-01-05 Hemolife Medical, Inc. Plasma detoxification and volume control system and methods of use
EP1951337B1 (de) * 2005-10-17 2018-08-01 Gambro Lundia AB Extrakorporale blutreinigung

Also Published As

Publication number Publication date
EP1944046B1 (de) 2010-08-11
CN101657224B (zh) 2012-03-28
KR20100014776A (ko) 2010-02-11
CA2675324A1 (en) 2008-07-17
RU2452518C2 (ru) 2012-06-10
ES2348189T3 (es) 2010-12-01
US20100044312A1 (en) 2010-02-25
RU2009130730A (ru) 2011-02-20
KR101456120B1 (ko) 2014-11-03
CO6231006A2 (es) 2010-12-20
EP1944046A1 (de) 2008-07-16
CA2675324C (en) 2015-07-07
ATE477009T1 (de) 2010-08-15
MX340241B (es) 2016-07-01
US20120312732A1 (en) 2012-12-13
MX2009007453A (es) 2010-02-17
CN101657224A (zh) 2010-02-24
WO2008084111A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
ATE477009T1 (de) Kit zur behandlung von erkrankungen im zusammenhang mit systemischen entzündungen
Stange et al. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers
Bouman et al. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing
Cole et al. High-volume haemofiltration in human septic shock
Venkataraman et al. Clinical review: extracorporeal blood purification in severe sepsis
JP2007504271A5 (de)
Karvellas et al. Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure
Atan et al. Techniques of extracorporeal cytokine removal: a systematic review of human studies
DE602006012307D1 (de) Membran zum filtrieren von wasser
EA200702601A1 (ru) Производные тиазола и их применение
JP2018534117A5 (de)
EA200702598A1 (ru) Производные тиазола и их применение
NO20054336D0 (no) Blandinger og fremgangsmate for diagnostisering og behandling av astma eller andre allergiske eller inflammatoriske sykdommer
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
Marais et al. Homozygous familial hypercholesterolemia and its management
JP2017507778A5 (ja) 高効率な逆浸透膜フィルタ
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
Honoré et al. Hemoadsorption therapy in the critically ill: solid base but clinical haze
Dominik et al. Reduction of Elevated Cytokine Levels in A cute/A cute‐on‐Chronic Liver Failure Using Super‐Large Pore Albumin Dialysis Treatment: An In Vitro Study
Hamdi et al. Review of extracorporeal membrane oxygenation and dialysis-based liver support devices for the use of nephrologists
JP2020521443A5 (de)
Cerdá et al. Renal replacement therapy in special settings: extracorporeal support devices in liver failure
JP2008538316A5 (de)
Kandiah et al. Extracorporeal devices
Schetz Evidence-based analysis of the role of hemofiltration in sepsis and multiorgan dysfunction syndrome